Abstract: Ventricular assist devices (VADs) are a lifesaving form of mechanical circulatory support in heart failure patients. However, VADs have not yet reached their full potential due to the associated side effects (thrombosis, bleeding, infection) related to the activation and damage of blood cells and proteins caused by mechanical stress and foreign materials. Studies of the effects of VADs on leukocytes are limited, yet leukocyte activation and damage including microparticle generation can influence both thrombosis and infection rates. Therefore, the aim was to develop a multicolor flow cytometry assessment of leukocyte microparticles (LMPs) using ovine blood and the CentriMag VAD as a model for shear stress. Ovine blood was pumped for 6 h in the CentriMag and regular samples analyzed for hemolysis, complete blood counts and LMP by flow cytometry during three different pump operating conditions (low flow, standard, high speed). The high speed condition caused significant increases in plasma-free hemoglobin; decreases in total leukocytes, granulocytes, monocytes, and platelets; increases in CD45
*Institute of Life Science, Swansea University Medical School; and †Calon Cardio-Technology Ltd, Institute of Life Science, Swansea, UK Abstract: Ventricular assist devices (VADs) are a lifesaving form of mechanical circulatory support in heart failure patients. However, VADs have not yet reached their full potential due to the associated side effects (thrombosis, bleeding, infection) related to the activation and damage of blood cells and proteins caused by mechanical stress and foreign materials. Studies of the effects of VADs on leukocytes are limited, yet leukocyte activation and damage including microparticle generation can influence both thrombosis and infection rates. Therefore, the aim was to develop a multicolor flow cytometry assessment of leukocyte microparticles (LMPs) using ovine blood and the CentriMag VAD as a model for shear stress. Ovine blood was pumped for 6 h in the CentriMag and regular samples analyzed for hemolysis, complete blood counts and LMP by flow cytometry during three different pump operating conditions (low flow, standard, high speed). The high speed condition caused significant increases in plasma-free hemoglobin; decreases in total leukocytes, granulocytes, monocytes, and platelets; increases in CD45 1 LMPs significantly increased in all pumping conditions. We propose that these two populations are released from granulocytes and T cells, respectively, but further research is needed to better characterize these two populations. Key Words: Flow cytometryOvine-Leukocyte-Microparticle-Shear stress-Ventricular assist-CD11b-HLA-DR-CentriMag.
Ventricular assist devices (VADs) are a life-saving form of mechanical circulatory support in refractory advanced heart failure patients, either as bridge to heart transplant or as destination therapy (1, 2) . However, VADs have not yet reached their full potential due to the associated side effects (stroke, bleeding, infection, and thrombosis) (3), related to the activation and damage to blood cells and proteins caused by mechanical stress and foreign materials.
Studies of the effects of VADs on leukocytes are limited, yet leukocyte activation and damage can potentially influence both thrombosis and infection rates (4) . Clinical data demonstrate that VADs can cause an overall decrease in leukocyte counts (5), supported by in vitro studies using bovine blood, which show a device-specific decrease in viable leukocytes (6) . Activation of granulocytes (5) and CD4 1 T cell apoptosis (7, 8) , initiated by CD40-ligand (CD40L) induction (9, 10) , have also been observed in VAD-patients. Studies on allosensitization have shown that VAD-patients have hyperreactive B cells and increased levels of alloantibodies, probably caused by stimulation by activated T cells as evidenced by increased levels of soluble CD40L (10, 11) . Finally, microparticle (MP) formation has been demonstrated in vitro (12, 13) , and clinically (14) (15) (16) (17) , suggesting a use for them as predictive markers of adverse events (15, 17) . MPs are membrane vesicles released from many different doi: 10.1111/aor.13068 cell types, through activation or apoptosis, with pro-inflammatory, pro-thrombotic, vasoconstrictive, and angiogenic effects (18) (19) (20) (21) . Based on these effects it is evident that MPs can play a role in VAD-related thrombosis. Since MPs are mediators of cellular cross-talk (22) , and MP levels are increased in patients with sepsis (23, 24) and parasitic infections (25) , it is likely that MPs are involved in VAD-related infections. Since different cell types can release MPs, using lineage markers is important to determine the origin of the cell type. CD45 has been used to demonstrate leukocyte MPs (LMPs) in VADs in vitro (12, 13) , and CD11b or CD45 have been used to demonstrate LMPs in VAD-patient samples (14, 16) . Unfortunately, the studies linking MPs to VAD-complications did not employ lineage markers (15, 17) , so it remains unknown which parent cell type(s) are predictive of VAD-complications and there is a need for further studies to better identify MP cellular provenance and quantitative functional capacity before and after LVAD implantation (26) .
The above mentioned examples demonstrate that VADs have an impact on leukocytes. However, the results are disarrayed by different device designs tested (including HeartMate XVE, HeartMate II, PVAD, HVAD, CentriMag, VentrAssist, Circulite, and RotaFlow), and a lack of lineage markers for leukocytes in the large animals used for preclinical studies, typically cows and sheep. This limits the ability to glean cell type specific effects during early in vitro and later in vivo testing.
The ovine model is used commonly for in vivo testing of VADs (27) (28) (29) (30) (31) (32) , but there is a need for standardized in vitro methods to rapidly assess leukocyte damage of new device designs to enable the development of VADs with fewer side effects. Therefore, the purpose of this study was to: (i) develop an in vitro method for studying LMPs in ovine blood that can be used by device developers during the screening of new device designs, and (ii) identify the parent cell type and activation status of the LMP formed in the CentriMag pump during in vitro testing.
METHODS

Blood preparation
Ovine blood was collected by venepuncture using an 11 G 3 44 mm stainless steel needle from live sheep (sourced from Ig-Innovations Ltd, Llandysul, UK, project license (PPL) number 40/3538). The blood was collected into 14% Citrate Phosphate Dextrose Adenine anticoagulant solution and antibiotics/antimycotics. Ovine venepuncture blood was used as opposed to abattoir blood used previously (33) due to the poor quality of the blood as a result of the release of mechanically fragile young erythrocytes from the spleen (34) .
Automated hematology analysis
Complete blood counts were measured using the veterinary analyzer Abacus Jr Vet 5 (Diatron, Budapest, Hungary).
Device operation and specifications
The extracorporeal ventricular assist device CentriMag CP (Abbott Vascular, Santa Clara, CA, USA) was tested using an in vitro testing circuit under constant hemodynamic conditions using three different operating conditions: herein called standard, low flow, and high speed. The standard operating conditions have been described in detail elsewhere (13) and followed the American Society for Testing and Materials (ASTM) standards (35, 36) . Briefly, the flow rate was 5 6 0.25 L/min, the differential pressure across the pump was adjusted using a custom-made clamp to 100 6 3 mm Hg, and the speed was 2200 rpm. The low flow condition differed by using a flow rate of 1 6 0.25 L/ min, and the high speed condition differed by using a speed of 3300 rpm.
Hemolysis
Blood samples (1 mL) were collected hourly and centrifuged at 4700 3 g for 7 min. The plasma supernatant (100 mL) was transferred from each aliquot into a deep well 96-well plate (StarLabs, Milton Keynes, UK) and diluted with 1 mL 0.1% Na 2 CO 3 solution (Sigma-Aldrich, Poole, UK). Diluted plasma (170 lL) was transferred into a 96-well flat bottom plate (ELISA plate, Greiner BioOne, Stonehouse, UK) and the absorbance was measured at three wavelengths: 380, 415, and 450 nm (POLARstar Omega, BMG LABTECH Ltd., Aylesbury, UK). The plasma-free hemoglobin (pfHb) was calculated by the Harboe direct spectrophotometric method (Eq. [1]) as described (37 (39) and is expressed on neutrophils, monocytes, and NK cells (40) . CD11b is upregulated on activated neutrophils in CPB patient blood (41) and has been suggested as a predictive marker of acute renal injury in this patient group (42) . Increased HLA-DR expression is a sign of T cell activation, and HLA-DR is upregulated on T cells in patients suffering from dilated cardiomyopathy (43) . On the contrary, HLA-DR expression on lymphocytes is decreased by CPB (41), so it is unclear how T cells might respond to the VAD. HLA-DR is also decreased on monocytes after CPB (44) (45) (46) . CD14 was first identified on the surface of monocytes and macrophages (47) . Although recent evidence shows its expression is not restricted to myeloid cells (48) , it was chosen because it is conventionally used as a monocyte marker for flow cytometry (49) . CD21 was chosen because of its use as an ovine B cell marker, targeting a subset of ovine B cells (50, 51) . Samples were vortexed and incubated on ice for 30 min in the dark. EasyLyse (1:20 with dH 2 O) was added to the samples which were immediately vortexed and incubated for 15 min at room temperature in the dark to lyse the red blood cells. Antibody-capture (AbC) beads (Thermo Fisher Scientific) were single-stained and used as compensation controls. Fluorescence-minus-one (FMO) controls were used for all antibodies by staining samples subjected to medium insult (240 min CentriMag time point). Isotype controls, isotype-FITC (AbD Serotec), and isotype-PE-Cy7 (eBioscience) were used for the activation markers also using the medium insult samples.
Data acquisition
Samples were acquired with a Navios flow cytometer equipped with three lasers (violet: 405 nm, blue: 488 nm, red: 638 nm), the standard filter configuration, and with Navios Cytometry List Mode Data Acquisition and Data Analysis Software Navios Cytometer 1.2 software (Beckman Coulter, High Wycombe, UK). Forward scatter (FSC), side scatter (SSC), and fluorescent voltages were set using unstained samples and all samples were recorded for 60 s. Stained AbC bead samples were acquired using a gate around the beads and capturing 10 000 events.
Quality control measures
The instrument was maintained using daily cleaning procedures recommended by the manufacturer throughout the study period. The quality control used the Flow-Check and Flow-Set Pro Fluorospheres (Beckman Coulter) and the protocols used were set-up by the manufacturer's technical support engineers.
Data analysis
All data were exported and analyzed using automatic compensation in Kaluza 1.5a (Beckman Coulter) using the data from the AbC bead samples. Data were displayed on FSC and SSC
I.L. PIEPER ET AL. E80
logarithmic axes and fluorescence displayed on biexponential axes (52) .
Leukocytes were gated and displayed on a contour density dot plot with 7AAD against CD45-PE. The healthy cell gate was set using the staurosporin-treated control to just outside the main contour of the healthy 7AAD-negative population (Supporting Information Fig. S1 ). Any events to the right of this border were considered 7AAD-positive necrotic leukocytes. Fragmented white blood cells (LMPs) still display CD45 but no longer contain DNA and because of their reduced size and complexity, and therefore lower SSC, end up below the healthy leukocytes on an SSC axes in the gate designated MP.
The gating strategy was drawn using the baseline samples and comparing the pattern differences to the pumped samples which were obvious (see for example Fig. 2 ). FMOs for all antibodies, and isotype controls for the activation markers CD11b and HLA-DR, were prepared but did not prove useful in this lyse-no wash protocol. Isotype controls were useful for setting the gates for the cells but not for the MPs (Supporting Information Fig. S2 ).
Statistical methods
Averages and SDs were calculated for all parameters and time points. LMP and complete blood counts were divided by the static control at time point 5 min to evaluate the relative increase or decrease caused by duration of pumping whilst minimizing donor-to-donor variability. For hemolysis, the background levels observed at 5 min were subtracted from all other measurements. The dataset consisted of repeated measurements of blood samples across three pumping conditions and 4 or 7 time points (7 for hemolysis, 4 for the other assays). Linear mixed models (LMM) were used to analyze the dataset. The reason we used a LMM was because the observations were in the form of repeated measures, which introduced possible hierarchical effects. By using LMM we were able to allow for these. In particular, we included individual level random effects (intercept and rate of change) in addition to the fixed effects. Differences between the groups at time point 360 min were assessed with the Kruskal-Wallis test and posthoc pairwise comparisons. All statistical data analysis was performed in SPSS version 22 (SPSS, Inc., Chicago, IL, USA).
RESULTS
Ovine blood was run through a 2 m loop, powered by a CentriMag under three different testing conditions (Table 1) .
Hematology
There was no significant difference in the red blood cell count for either the static or the pumped samples (Fig. 1A) . The white cells decreased significantly in the high speed condition (P 5 0.001). Both the standard and the high speed caused a significant decrease in the granulocyte count compared to the static control (P 5 0.006 and P < 0.001, respectively) but only the high speed condition caused a decrease in the monocyte count versus the static control (P 5 0.003). There were no changes to the lymphocyte count. The platelets decreased significantly in both the low flow and high speed condition compared to the static (P 5 0.005 and P 5 0.008, respectively).
Hemolysis
The pfHb levels for all testing conditions increased over time as expected (Fig. 1B) . The lowest pfHb levels were observed in the tests run at low flow, with pfHb measured at 0.7 6 0.6 mg/dL at 6 h. The highest levels of pfHb were observed in the tests run at high speed; pfHb measured at 7.3 6 5.0 mg/dL at 6 h, which was significantly different compared to the static control (P < 0.001).
Leukocyte microparticles
All pumping conditions caused a significant increase in CD45
1 LMPs compared to the static control (low flow: P 5 0.005, standard: P 5 0.004, high speed: P < 0.001; Fig. 1C ). An example of the flow cytometry data from the high speed condition over time is shown (Supporting Information  Fig. S3 ). The antibodies were tested on baseline blood to confirm that they could detect the target parent cells (Supporting Information Fig. S4 ). CD14-BDV500 detected granulocytes (high SSC/ CD14 dull ), and monocytes (medium-high SSC/ CD14 1 ). CD21-PE stained a B cell subset (medium SSC/CD21 1 ). CD11b-FITC mainly stained granulocytes, monocytes, and a subset of lymphocytes. HLA-DR-PE-Cy7 targeted monocytes and a subset of lymphocytes. Gated medium-high SSC/CD14 1 monocytes were CD11b 1 and about 60% also expressed HLA-DR. Of the CD21 1 B cells, around 50% were HLA-DR 1 /CD11b 2 , and approximately 40% were double positive.
Characterization of LMPs
LMPs generated during pump testing expressed CD11b and/or HLA-DR (Fig. 2) (Fig. 3A) . All three populations were negative for both CD14 and CD21 (Fig. 3B) , so are unlikely to be derived from monocytes or the CD21 1 B cell subset. On specifically seeking CD14 1 or CD21
1
LMPs there were none detectable (Supporting Information Fig. S5 ). Since HLA-DR expression was restricted to the monocyte/lymphocyte SSC area (Fig. 2C) , the parental lineage is unlikely to be granulocytes and we propose T cells or CD21 2 B cells as the most likely parental lineages for the CD11b dull HLA-DR 1 LMPs. The parental lineage for the CD11b bright HLA-DR 2 population is most likely granulocytes, due to their high CD11b expression (Fig. 2B) and lack of HLA-DR (Fig. 2C) . The small CD11b bright HLA-DR 2 population could be a further activated subset from either of the granulocyte or lymphocyte MP populations, as both activated T cells can increase their CD11b expression (53) , and activated neutrophils can increase their HLA-DR expression (54) .
Influence of pumping condition on activated LMP production
The standard and the high speed condition caused a significant increase in the CD11b bright HLA-DR 2 LMPs versus the static control (P 5 0.027 and P < 0.001, respectively) (Fig. 3C) . The high speed 
HLA-DR
1 LMPs compared to the static control (P < 0.001) (Fig. 3D) . The CD11b dull
1
LMPs significantly increased during all pumping conditions compared to the static control (P < 0.001) (Fig. 3E) . Finally, at 360 min, the high speed condition caused significantly more CD11b bright
HLA-DR
2 LMPs compared to CD11b dull HLA-DR 1 LMPs (P 5 0.002).
DISCUSSION
To the best of our knowledge this is the first study to describe a four color flow cytometry panel for ovine leukocytes; previous studies have used single or two-color approaches (55) (56) (57) (58) . It is also the first time LMPs displaying activation markers have been shown to be generated during in vitro VAD testing, and the first time LMPs have been demonstrated in vitro using ovine blood. This study also represents the first ovine blood damage profile for the CentriMag operated under standard conditions (as defined by ASTM (35,36) ). The panel described herein can be used to detect differences in LMP generation due to shear stress as demonstrated by pumping whole blood in the CentriMag, a suggested benchmark for in vitro VAD-testing (13), at different operating conditions. The antibodies used were chosen on two criteria: (i) directly conjugated to fluorochromes for replicability and uptake by other users, and (ii) cross reactivity to ovine, bovine, and human blood cells, to yield a translational research tool suitable for device developers using animals in the preclinical phase and then progressing to clinical studies.
Similarly to our previously published bovine CentriMag blood damage profile (13), the standard condition did not cause any significant differences to ovine total red cell, white cell, or platelet counts. However, now we also studied the leukocyte subsets, and show that the standard condition caused a significant reduction in the granulocyte count. Perhaps because the lymphocytes are the most prevalent white blood cell type in bovine and ovine blood (59) , and lymphocyte counts remained constant in this ovine blood study, they mask the decreasing granulocytes levels when only the total white blood cell count is measured. The high speed condition caused a reduction in both granulocyte and monocyte counts, but lymphocytes remained constant. This reflects either the resilience of lymphocytes or their abundance in the ovine circulation (59) . Consideration of lymphocyte subsets and/or a higher resolution method such as absolute counting using flow cytometry (33) might be required to assess any decrease in lymphocyte cell numbers. Both the low flow and the high speed conditions significantly decreased platelet counts. Platelet activation is caused by both an increase in residence time (as in the low flow condition) (60) , and by high shear stress (61, 62) which could lead to lysis and/or aggregation and the observed reduction in numbers. Interestingly, our previous study of bovine blood using the extracorporeal RotaFlow and the intracorporeal VentrAssist pumps observed an increase in platelet numbers (12) . This increase was hypothesized due to LMP being falsely detected as platelets by the hematology analyzer due to the concomitant decrease in leukocytes and increase in CD45
1 LMPs (12) . Although the high speed condition in this current study caused a reduction in leukocytes and an increase in CD45 1 LMPs, there was no increase in platelets. This could be due to different hematology analyzers being used in the two studies (CELL-DYN Ruby vs. Abacus Jr Vet 5).
The hemolysis data showed evidence of increased resilience of ovine venepuncture versus bovine abattoir erythrocytes to the effects of shear. Levels of pfHb obtained with ovine blood were one quarter of those obtained in bovine blood after 360 min pumping in the CentriMag at the standard condition (2.5 6 1.0 vs. 10 6 1.5 mg/dL), with mg NIH roughly one-third in ovine compared to bovine blood (0.38 6 0.15 compared to 1.10 6 0.5 mg/100 L) (13) . In our previous multispecies comparison study, in which we evaluated the response to shear caused by a rheometer, we also observed greater hemolysis in bovine abattoir compared to ovine venepuncture blood at high shear (75 vs. 50 mg/dL at 8000/s, respectively), although this difference was not statistically significant (34) .
The standard condition in this study caused a significant increase in ovine CD45
1 LMPs, as previously observed in bovine blood (13) . In addition, the CD45
1 LMPs significantly increased in the low flow and the high speed conditions as well. We have confirmed the LMP identity in a previous study (12) , where we showed that: CD45
1 LMPs were a fraction of the size compared to CD45 1 leukocytes using imaging cytometry; we showed MPs, morphologically different from platelets, in association with leukocytes using scanning electron microscopy; and we showed that, when using bovine activated platelet marker GC5A, the FSC/ SSC region co-habited by MPs and platelets consists of three separate populations: CD45 . These were all negative for CD14 and CD21, suggesting they are not derived from monocytes or the CD21 1 B cell subset. However, it is possible that as there are relatively few monocytes in ovine blood (59); monocyte-derived LMPs might simply be relatively rare and undetectable. The remaining major cell types are neutrophils, T cells, and CD21 2 B cells. Neutrophils express CD11b, and have been shown to produce CD11b 1 MPs when activated in vitro (63) (64) (65) . Considering that the granulocyte cell count (Fig. 1) and the CD11b bright HLA-DR 2 frequency (Fig. 3C) MPs. That granulocytes and T cells would be the cell types most affected in the VAD in vitro is supported by clinical evidence showing the activation of both granulocytes and T cells in VAD-patients (5, 7, 8) . This study shed light on two important aspects of leukocyte MPs in relation to VADs. Firstly, it showed that CD11b 1 MPs are generated in VADs, which could have implications for pump thrombosis. Low levels of CD11b 1 LMPs are a risk factor in patients suffering non-ST elevated acute coronary syndrome, as low levels are associated with a higher number of occluded arteries, higher number of >50% stenosis, higher number of stenosed arteries, and higher frequency of recurring cardiovascular events (66) . The decline in CD11b
1 LMPs is suggestive of their consumption in the occlusions, since CD11b
1 levels negatively correlate with thrombus weight in a mouse model (19) . The mechanism is likely to be through a M b 2 interaction with resting platelets, causing them to become activated (65) .
Secondly, it showed that different LMP subtypes respond differently to changes in operating conditions. The CD11b dull HLA-DR 1 LMPs were sensitive to pumping and significantly increased regardless of the operating conditions. However, they did not respond to a further increase in speed. In contrast, the levels of CD11b bright HLA-DR 2 LMPs were not significantly different from the static control in any other condition than the high speed so are seemingly more affected by increasing speed than the CD11b dull HLA-DR 1 LMPs. Hence, the CD11b dull HLA-DR 1 LMPs show potential as a positive control for pumping versus static samples, and the CD11b bright HLA-DR 2 LMPs may be able to differentiate between the effects of pump designs on LPM generation if the pumps differ in shear stress. The different responses to the operating conditions further supports that these LMPs are of different cellular origins. In vitro studies of human leukocytes under shear stress have revealed that the fluid shear response is not uniform among all cells. At low shear stress levels (0.2 dyn/cm 2 for 5 min), about 33% of leukocytes respond with pseudopodia projection (67) . These first responders could be lymphocytes since they make up 17-48% of the human leukocyte count, whereas neutrophils make up 40-75% (68) . The number of human leukocytes responding to shear stress increases with each 1 dyn/cm 2 (67) . This could be the neutrophils as they have been described to display a doseresponse relationship with both shear magnitude and time in vitro using a cone-and-plate viscometer, with L-selectin shedding as the measure (69) . Lastly, the migration of human T cells and neutrophils in vitro also differs with T cells migrating against the fluid flow and neutrophils migrating with it (70).
Study limitations
One study limitation was to find antibodies that target ovine blood cells. For example, there is no ovine platelet lineage marker that is not affected by activation which is why platelet MPs were not studied. This also means we cannot analyze the potential platelet contamination within the leukocyte MP population. However, a confirmatory experiment using human blood double-stained with platelet and leukocyte lineage markers CD41 and CD45, respectively, pumped using the "high speed" protocol, showed that within the CD45 1 MP population, there is a 10% contamination of double-positive platelet aggregates (Supporting Information Fig. S6 ). Thus, if the assay is used with human blood, an initial platelet-discrimination gate can be set to exclude platelet-MP aggregates from further analysis steps, if desired.
In addition, there is no directly conjugated antiovine granulocyte antibody available to confirm that the CD11b bright MPs were of neutrophil origin. For future studies, in-house conjugation of the granulocyte-monocyte targeting antibody clone, DH59B (56), could be used in combination with anti-CD14 to distinguish the granulocyte (DH59B 1 CD14 1 ) and monocyte (DH59 bright CD14-bright ) MPs.
Although there is a vast amount of literature describing that MPs can be identified using lineage markers (21, (71) (72) (73) , a couple of studies have described contradictory results. Monocyte and lymphocyte MPs, in particular B cell MPs, have been described to lack lineage markers (74, 75) . In addition, human malignant B cell MPs, but not T cell MPs, have been described to express HLA-DR (75) , hence the CD11b dull HLA-DR 1 LMPs could be B cell MPs that are not expressing CD21; this remains to be proven.
The method described herein was developed as a whole blood wash-no-lyse protocol in order to fit around the routine hemolysis procedures of a device testing lab. As per the ASTM standard, hemolysis testing should be carried out on fresh blood for a total of 6 h (36). In practice, this means that any samples collected from such a test will be available in the evening. We deemed an MP isolation method including several centrifugation steps would be too time-consuming for it to be practical to do in addition to a hemolysis test for most device developers. Thus, we opted for a rapid whole blood staining protocol to make it user friendly.
Lastly, conventional flow cytometric methods use standardization beads to define the initial FSC/SSC scatter gate for further MP analysis. Although we did not use such beads, the method is fully compatible with beads as exemplified by a subsequent acquisition of Megamix beads using the same acquisition protocol. When displaying the MP population in a Megamix gate created around the FSC/SSC of beads 900 nm and smaller, 92% of the CD45 1 MP population was within the gate (Supporting Information Fig. S7 ). Thus, an additional Megamix bead gate could be introduced, if desired.
CONCLUSIONS
This first report of the damage profile of ovine blood exposed to the CentriMag pump shows that ovine venepuncture blood may potentially be more resilient than bovine abattoir blood to shear stress. This is supported by our previous multispecies rheometry study (34) . As expected, the high speed condition was the most detrimental regarding all parameters. This condition caused a significant decrease in total leukocytes, granulocytes, monocytes, and platelets; an increase in pfHb; and an increase in CD45
1 LMPs, and, using a four-color panel for ovine leukocytes for the first time, an increase in three novel LMP populations: CD11b bright HLA-DR . We propose that this multicolor panel can be used by device developers to test and develop VADs with better blood handling capacity for reduced side effects. Our next step is to repeat this study in bovine blood using several device types and to expand the flow cytometry panel used to include granulocyte and T cell markers based on the results presented herein. This will confirm if the panel is useful for monitoring LMP formation during in vitro testing in bovine blood and promote its further adoption by the industry. It will also enable us to identify the parental lineage of LMPs and undertake pump comparison testing. This study also highlights the need to better understand the formation and functional effects of circulating LMPs in humans implanted with VADs.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article at the publisher's website: FIG. S2 . Fluorescence-minus-one (FMO) and isotype controls. Ovine blood entered into the CentriMag loop and run at 3300 rpm, 5 L/min (high speed condition). Samples were obtained after 4 h and stained with CD14-BDV500, CD21-PE, CD11b-FITC, and HLA-DR-PE-Cy7 (ALL ABS). In addition, FMO controls were created by omitting one of the antibodies (i.e., CD14-FMO does not contain CD14-BDV500 but the three other antibodies). Isotype controls were created by swapping either CD11b-FITC or HLADR-PE-Cy7 for its isotype control as specified by the manufacturer. Gates were set based on the baseline sample (see Fig. S4 ) and applied to the samples to assess the usefulness of the FMO and isotype controls. 1 LMPs were gated as previously described. (D) A "microparticle" gate was created to include beads 0.9 mm on a FSC/SSC scatter plot. (E) The CD45
1 LMPs were displayed on a FSC/ SSC scatter plot to assess whether or not they fall within the "microparticle" gate (92% compatibility).
